Alexander Saltzman - Related publications

Affiliations: 
Chemical and Biomolecular Engineering Tulane University School of Science and Engineering 
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
24 most relevant papers in past 60 days:
Year Citation  Score
2022 Chen P, Hu J, Han X, Chen Y. Advances in the functional roles of N6-methyladenosine modification in cancer progression: mechanisms and clinical implications. Molecular Biology Reports. PMID 35025029 DOI: 10.1007/s11033-022-07126-5   
2022 Yao S, Meiling L, Jin FL, Qian C, Hua H, Qing L. Identification of potential immunotherapy biomarkers for breast cancer by bioinformatics analysis. Bioscience Reports. PMID 35037689 DOI: 10.1042/BSR20212035   
2022 Qian J, Huang C, Zhu Z, He Y, Wang Y, Feng N, He S, Li X, Zhou L, Zhang C, Gong Y. NFE2L3 promotes tumor progression and predicts a poor prognosis of bladder cancer. Carcinogenesis. PMID 35022660 DOI: 10.1093/carcin/bgac006   
2022 Bolatkan A, Asada K, Kaneko S, Suvarna K, Ikawa N, Machino H, Komatsu M, Shiina S, Hamamoto R. Downregulation of METTL6 mitigates cell progression, migration, invasion and adhesion in hepatocellular carcinoma by inhibiting cell adhesion molecules. International Journal of Oncology. 60. PMID 34913069 DOI: 10.3892/ijo.2021.5294   
2022 Qin D, Ni C, Tan B, Huang S, Deng B, Huang Z. LINC01207 promotes prostate cancer progression by sponging miR-1182 to upregulate AKT3. Oncology Letters. 23: 57. PMID 34992689 DOI: 10.3892/ol.2021.13175   
2022 Qian HG, Wu Q, Wu JH, Tian XY, Xu W, Hao CY. Long non‑coding RNA LINC00238 suppresses the malignant phenotype of liver cancer by sponging miR‑522. Molecular Medicine Reports. 25. PMID 35014686 DOI: 10.3892/mmr.2022.12587   
2022 Salvi A, Young AN, Huntsman AC, Pergande MR, Korkmaz MA, Rathnayake RA, Mize BK, Kinghorn AD, Zhang X, Ratia K, Schirle M, Thomas JR, Brittain SM, Shelton C, Aldrich LN, et al. PHY34 inhibits autophagy through V-ATPase V0A2 subunit inhibition and CAS/CSE1L nuclear cargo trafficking in high grade serous ovarian cancer. Cell Death & Disease. 13: 45. PMID 35013112 DOI: 10.1038/s41419-021-04495-w   
2022 Gao Z, Xu M, Yue S, Shan H, Xia J, Jiang J, Yang S. Abnormal sialylation and fucosylation of saliva glycoproteins: Characteristics of lung cancer-specific biomarkers. Current Research in Pharmacology and Drug Discovery. 3: 100079. PMID 35005612 DOI: 10.1016/j.crphar.2021.100079   
2022 Chatterjee M, Sengupta S. Human Satellite III long non-coding RNA imparts survival benefits to cancer cells. Cell Biology International. PMID 35005799 DOI: 10.1002/cbin.11761   
2022 Zou T, Wang Y, Dong L, Che T, Zhao H, Yan X, Lin Z. Stabilization of SETD3 by deubiquitinase USP27 enhances cell proliferation and hepatocellular carcinoma progression. Cellular and Molecular Life Sciences : Cmls. 79: 70. PMID 35018513 DOI: 10.1007/s00018-021-04118-9   
2022 Kim LC, Simon MC. Hypoxia-Inducible Factors in Cancer. Cancer Research. 82: 195-196. PMID 35042744 DOI: 10.1158/0008-5472.CAN-21-3780   
2022 Sun Y, Tian Y, He J, Tian Y, Zhang G, Zhao R, Zhu WJ, Gao P. Linc01133 contributes to gastric cancer growth by enhancing YES1-dependent YAP1 nuclear translocation via sponging miR-145-5p. Cell Death & Disease. 13: 51. PMID 35017464 DOI: 10.1038/s41419-022-04500-w   
2022 Wu T, Yang Y, Zhang B, Zhang ZS, Zhou S, Jia GZ, Liu SQ, He XL, He JX, Wang N. EDDM3A drives gastric cancer progression by promoting HIF-1α-dependent aerobic glycolysis. Oncogenesis. 11: 3. PMID 35039478 DOI: 10.1038/s41389-022-00379-6   
2022 Landry M, Nelson D, Choi E, DuRoss A, Sun C. Development of a G2/M arrest high-throughput screening method identifies potent radiosensitizers. Translational Oncology. 16: 101336. PMID 34986454 DOI: 10.1016/j.tranon.2021.101336   
2022 Na S, Ying L, Jun C, Ya X, Suifeng Z, Yuxi H, Jing W, Zonglang L, Xiaojun Y, Yue W. Study on the molecular mechanism of nightshade in the treatment of colon cancer. Bioengineered. 13: 1575-1589. PMID 35012428 DOI: 10.1080/21655979.2021.2016045   
2022 Xu J, Su SM, Zhang X, Chan UI, Adhav R, Shu X, Liu J, Li J, Mo L, Wang Y, An T, Lei JH, Miao K, Deng CX, Xu X. ATP11B inhibits breast cancer metastasis in a mouse model by suppressing externalization of non-apoptotic phosphatidylserine. The Journal of Clinical Investigation. PMID 35025764 DOI: 10.1172/JCI149473   
2022 Cackowski FC, Heath EI. Prostate cancer dormancy and recurrence. Cancer Letters. 524: 103-108. PMID 34624433 DOI: 10.1016/j.canlet.2021.09.037   
2022 Zheng S, Zou Y, Tang Y, Yang A, Liang JY, Wu L, Tian W, Xiao W, Xie X, Yang L, Xie J, Wei W, Xie X. Landscape of cancer-associated fibroblasts identifies the secreted biglycan as a protumor and immunosuppressive factor in triple-negative breast cancer. Oncoimmunology. 11: 2020984. PMID 35003899 DOI: 10.1080/2162402X.2021.2020984   
2022 Guo T, Zhang Z, Zhu L, Chen W, Ding Y, Li W, Huang Y, Huang J, Pan X. TRIM55 suppresses malignant biological behavior of lung adenocarcinoma cells by increasing protein degradation of Snail1. Cancer Biology & Therapy. 1-10. PMID 34974792 DOI: 10.1080/15384047.2021.2004835   
2022 Wang T, Zhu X, Wang K. CircMIIP Contributes to Non-Small Cell Lung Cancer Progression by Binding miR-766-5p to Upregulate FAM83A Expression. Lung. PMID 35013754 DOI: 10.1007/s00408-021-00500-3   
2022 Martinez JD, Mo Q, Xu Y, Qin L, Li Y, Xu J. Common Genomic Aberrations in Mouse and Human Breast Cancers with Concurrent P53 Deficiency and Activated PTEN-PI3K-AKT Pathway. International Journal of Biological Sciences. 18: 229-241. PMID 34975329 DOI: 10.7150/ijbs.65763   
2022 Zawieracz K, Eckert MA. Isolation of Normal and Cancer-Associated Fibroblasts. Methods in Molecular Biology (Clifton, N.J.). 2424: 155-165. PMID 34918293 DOI: 10.1007/978-1-0716-1956-8_10   
2022 Wang L, Liu X, Liu Z, Wang Y, Fan M, Yin J, Zhang Y, Ma Y, Luo J, Li R, Zhao X, Zhang P, Zhao L, Fan J, Chen Y, et al. Network models of prostate cancer immune microenvironments identify ROMO1 as heterogeneity and prognostic marker. Scientific Reports. 12: 192. PMID 34996995 DOI: 10.1038/s41598-021-03946-w   
2022 Dey A, Eisenberg S, Birnbaum R, Sharp DJ. 3D-on-2D: A Physiologically Relevant and Gel-Free In Vitro Coculture Method to Assay Antimetastatic Agents. Methods in Molecular Biology (Clifton, N.J.). 2423: 103-107. PMID 34978692 DOI: 10.1007/978-1-0716-1952-0_10